Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy

NIH RePORTER · NIH · R33 · $391,227 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10400915
Project number
5R33NS112407-03
Recipient
CINCINNATI CHILDRENS HOSP MED CTR
Principal Investigator
NANCY RATNER
Activity code
R33
Funding institute
NIH
Fiscal year
2022
Award amount
$391,227
Award type
5
Project period
2019-09-01 → 2023-02-28